FDA testing indicates heartburn drug Zantac does not form carcinogen in users
The U.S. Food and Drug Administration on Friday downplayed the risk from contamination of the already recalled popular heartburn drug Zantac, and said its tests suggest it does not cause carcinogens to form in patients.
"are similar to the levels you would expect to be exposed to if you ate common foods like grilled or smoked meats."on ranitidine products and showed that some versions of the drug had as much as nine times the regulator's"acceptable limit" for NDMA.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA Approves First Artificial TumorWASHINGTON—Following years of research and testing, the U.S. Food and Drug Administration officially approved a groundbreaking artificial tumor Tuesday, marking the first time a synthetic malignant growth has been cleared for use in patients across the country. “There were obviously significant complications in devising a tumor substitute the human body would accept, but we now have an artificial neoplasm that serves the same physiological functions as an organic abnormal growth of tissue,” said Jeffrey Shuren of the FDA’s Center for Devices and Radiological Health, adding that the polymer-based lump can be safely implanted in patients regardless of age, health, or medical history during a minimally invasive and relatively quick two-hour surgical procedure. “This synthetic tumor is remarkably lightweight, malignant, and capable of naturally metastasizing throughout the body. It also has the benefit of being incredibly small—roughly the size of a dime—but once in the body, it will grow two to three times in size and will get to work immediately replicating itself.” Shuren added that while initial prototypes of the device had only enough battery power to last a few days, the approved version is capable of going for several years or more, or until its objective has been completed.
Leer más »
Trump to pick Texas cancer doctor to head FDAPresident Donald Trump on Friday will nominate Stephen Hahn, a well-regarded cancer specialist and hospital administrator, to lead the FDA, three people familiar with the decision told POLITICO. If confirmed by the Senate, the top FDA post would mark Hahn&39;s first foray into public service in a quarter
Leer más »
FDA issues Halloween warning: Decorative contact lenses can cause blindness, infection, cornea scratches'Wouldn't it be cool to have vampire eyes for Halloween? Or deep violet eyes to match your purple sweater? How about your favorite sports team's logo on your eyes just for fun?' the FDA warning begins.
Leer más »
Cramer: This biotech stock could be worth over $100 billion on an FDA approvalBiogen, with a $54.1 billion market cap, 'could be worth twice that if all goes well' with regulators, Jim Cramer says.
Leer más »
FDA panel recommends withdrawing approval of Makena drug, used to prevent preterm birthsA committee for the US Food and Drug Administration now recommends that the approval of Makena, a drug used to reduce the risk of preterm births, should be withdrawn — and some women who have used the medication are sounding the alarm
Leer más »
Trump to pick Texas cancer doctor to head FDA
Leer más »